In the seventeen month time period of this retrospective study, there were 11,719 HBsAg tests ordered for 9,930 patients (with some patients being tested two or more separate times during the time ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Up to 19% of patients who received JNJ-3989 achieved ...

Age Dependency of the Prognostic Impact of Tumor Genomics in Localized Resectable MYCN-Nonamplified Neuroblastomas. Report From the SIOPEN Biology Group on the LNESG Trials and a COG Validation Group ...

Please provide your email address to receive an email when new articles are posted on . HBV-infected children treated with combination PEG-INF a-2b/nucleos(t)ide analogues achieved higher HBsAg loss ...

October 30, 2006 — The US Food and Drug Administration (FDA) has approved a third-generation, point-of-care qualitative immunoassay for HIV-1 antibodies (Reveal G3) that eliminates the need for ...

Patients with chronic hepatitis B virus (HBV) infection in the immune-tolerant phase may still experience hepatic inflammation and disease progression, and could benefit from early antiviral treatment ...

Aligos Belgium presented research on ALG-005398, a first representative of a series of non-heteroaryldihydropyrimidines (HAPs) class I capsid-assembly modulators, that was identified using ...